CTAS Remains Committed To Cost Cutting, Enhancing Cash Flows

Analyst John Healy of Northcoast Research maintains his "buy" rating on Cintas (NASDAQ: CTAS). The target price for CTAS is set to $32.

Cintas has indicated that its top-line growth will be linked to the economic recovery, which is expected to be a slow and gradual process. “CTAS believes that over the long-run the company should be able to generate low double digit revenue growth and meaningful operating leverage which should allow for earnings growth to outpace top-line growth,” the analyst says.

“CTAS appears poised to continue to maintain a strong balance sheet in the near-term with the goal of remaining flexible for both small and large acquisition opportunities that may present themselves to the company,” the analyst adds.

More Analyst Ratings here